• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Calcium Gluconate Injection

 Status: Currently in Shortage

 » Date first reported: 01/10/2013
 » Therapeutic Categories: Cardiovascular; Endocrinology/Metabolism; Gastroenterology; Other; Pediatric; Pulmonary/Allergy

American Regent/Luitpold (Reverified 11/17/2014)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10%, 50 mL vial; Calcium (0.465 mEq/mL), Preservative Free (NDC 0517-3950-25) Unavailable- no product available for release. No plan to manufacture. American Regent is currently not releasing Calcium Gluconate 50 mL vial Shortage per Manufacturer: Manufacturing delay. Other
10%, 100 mL vial; Calcium (0.465 mEq/mL), Preservative Free (NDC 0517-3900-25) Unavailable-product on backorder and will be made available as it is released. American Regent is currently not releasing Calcium Gluconate 50 mL vial Shortage per Manufacturer: Manufacturing delay. Delay in shipping of the drug

Fresenius Kabi USA, LLC (Revised 11/07/2014)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10% , 10 mL vial; Calcium (0.465 mEq/mL), Preservative Free 1 g/ 10 mL, SDV (NDC 63323-311-10) 2 & 3 month dating available upon request. Next release anticipated November 2014. Check wholesalers for inventory. Demand increase for the drug
10% , 50 mL vial; Calcium (0.465 mEq/mL), Preservative Free 5 g/ 50 mL, SDV (NDC 63323-311-50) Backordered. Next releast anticipated November 2014. Demand increase for the drug
10% , 100 mL vial; Calcium (0.465 mEq/mL), Preservative Free 10 g/ 100 mL, PBP (NDC 63323-311-61) Backordered. Next release anticipated November 2014. Demand increase for the drug
-
-